Other products from "PRECISION BIOLOGIC INC"
No Primary DI Version or Model Catalog Number Device Description Product Code Product Code Name Device Class Brand Name
1 00843876000268 FDP07-15 GJT Plasma, Coagulation Factor Deficient CRYOcheck™ Factor VII Deficient Plasma
2 00843876000312 FDP09-15 GJT Plasma, Coagulation Factor Deficient CRYOcheck™ Factor IX Deficient Plasma
3 00843876000305 FDP09-10 GJT Plasma, Coagulation Factor Deficient CRYOcheck™ Factor IX Deficient Plasma
4 00843876000251 FDP07-10 GJT Plasma, Coagulation Factor Deficient CRYOcheck™ Factor VII Deficient Plasma
5 00843876000381 FDPK-10 GJT Plasma, Coagulation Factor Deficient CRYOcheck™ Prekallikrein Deficient Plasma
6 00843876000435 PNP-10 GGW Test, Time, Partial Thromboplastin CRYOcheck™ Platelet Lysate
7 00843876000046 CCN-40 GGN Plasma, Coagulation Control CRYOcheck™ Pooled Normal Plasma
8 00843876000039 CCN10-10 GGN Plasma, Coagulation Control CRYOcheck™ Pooled Normal Plasma
9 00843876000022 CCN-15 GGN Plasma, Coagulation Control CRYOcheck™ Pooled Normal Plasma
10 00843876000015 CCN-10 GGN Plasma, Coagulation Control CRYOcheck™ Pooled Normal Plasma
11 00843876000428 CCS-30 GGP Test, Qualitative And Quantitative Factor Deficiency CRYOcheck™ Clot S™
12 00843876000411 CCS-15 GGP Test, Qualitative And Quantitative Factor Deficiency CRYOcheck™ Clot S™
13 00843876000473 CHK50-30 GIR Reagent, Russel Viper Venom CRYOcheck™ LA Check™
14 00843876000466 CHK80-10 GIR Reagent, Russel Viper Venom CRYOcheck™ LA Check™
15 00843876000459 CHK-40 GIR Reagent, Russel Viper Venom CRYOcheck™ LA Check™
16 00843876000442 CHK-10 GIR Reagent, Russel Viper Venom CRYOcheck™ LA Check™
17 00843876000558 CCCF08 CCCF08 CRYOcheck Chromogenic Factor VIII is for clinical laboratory use in the quantita CRYOcheck Chromogenic Factor VIII is for clinical laboratory use in the quantitative determination of factor VIII activity in 3.2% citrated human plasma. It is intended to be used in identifying factor VIII deficiency and as an aid in the management of hemophilia A in individuals aged 2 years and older. For in vitro diagnostic use GGP Test, Qualitative And Quantitative Factor Deficiency 2 CRYOcheck Factor VIII Chromogenic
18 00843876000220 FDP02-15 GJT Plasma, Coagulation Factor Deficient CRYOcheck™ Factor II Deficient Plasma
19 00843876000213 FDP02-10 GJT Plasma, Coagulation Factor Deficient CRYOcheck™ Factor II Deficient Plasma
20 00843876000176 CCWLP-10 GGC Control, Plasma, Abnormal CRYOcheck™ Weak Lupus Positive Control
21 00843876000169 CCWLP-05 GGC Control, Plasma, Abnormal CRYOcheck™ Weak Lupus Positive Control
22 00843876000152 CCLP-10 GGN,GGC Plasma, Coagulation Control,Control, Plasma, Abnormal CRYOcheck™ Lupus Positive Control
23 00843876000145 CCLP-05 GGN,GGC Plasma, Coagulation Control,Control, Plasma, Abnormal CRYOcheck™ Lupus Positive Control
24 00843876000091 ARP2-10 GGC,GGN Control, Plasma, Abnormal,Plasma, Coagulation Control CRYOcheck™ Abnormal 2 Reference Control
25 00843876000084 ARP1-10 GGN,GGC Plasma, Coagulation Control,Control, Plasma, Abnormal CRYOcheck™ Abnormal 1 Reference Control
26 00843876000077 ARP1-05 GGN,GGC Plasma, Coagulation Control,Control, Plasma, Abnormal CRYOcheck™ Abnormal 1 Reference Control
27 00843876000374 FDP12-15 GJT Plasma, Coagulation Factor Deficient CRYOcheck™ Factor XII Deficient Plasma
28 00843876000367 FDP12-10 GJT Plasma, Coagulation Factor Deficient CRYOcheck™ Factor XII Deficient Plasma
29 00843876000497 CSD GGP Test, Qualitative And Quantitative Factor Deficiency C & S Diluent
30 00843876000206 CCNRP-10 GGN Plasma, Coagulation Control CRYOcheck™ Normal Reference Plasma
31 00843876000190 CCNRP-05 GGN Plasma, Coagulation Control CRYOcheck™ Normal Reference Plasma
32 00843876000107 CCA1-10 GGC,GGN Control, Plasma, Abnormal,Plasma, Coagulation Control CRYOcheck™ Abnormal 1 Control
33 00843876000404 CCC-30 GGP Test, Qualitative And Quantitative Factor Deficiency CRYOcheck™ Clot C™
34 00843876000398 CCC-15 GGP Test, Qualitative And Quantitative Factor Deficiency CRYOcheck™ Clot C™
35 00843876000541 CCLN-05 CCLN-05 Prepared from human source plasma and recommended as a negative control in assay Prepared from human source plasma and recommended as a negative control in assays for lupus anticoagulant. GGN Plasma, Coagulation Control CRYOcheck Lupus Negative Control
36 00843876000534 CCLN-10 CCLN-10 Prepared from human source plasma and recommended as a negative control in assay Prepared from human source plasma and recommended as a negative control in assays for lupus anticoagulant. GGN Plasma, Coagulation Control CRYOcheck Lupus Negative Control
37 00843876000060 RCN-10 GIZ Plasma, Control, Normal CRYOcheck™ Reference Control Normal
38 00843876000053 RCN-05 GIZ Plasma, Control, Normal CRYOcheck™ Reference Control Normal
39 00843876000336 FDP10-15 GJT Plasma, Coagulation Factor Deficient CRYOcheck™ Factor X Deficient Plasma
40 00843876000329 FDP10-10 GJT Plasma, Coagulation Factor Deficient CRYOcheck™ Factor X Deficient Plasma
41 00843876000244 FDP05-15 GJT Plasma, Coagulation Factor Deficient CRYOcheck™ Factor V Deficient Plasma
42 00843876000275 FDP08-10 GJT Plasma, Coagulation Factor Deficient CRYOcheck™ Factor VIII Deficient Plasma
43 00843876000299 FDP08-40 GJT Plasma, Coagulation Factor Deficient CRYOcheck™ Factor VIII Deficient Plasma
44 00843876000282 FDP08-15 GJT Plasma, Coagulation Factor Deficient CRYOcheck™ Factor VIII Deficient Plasma
45 00843876000480 SUR-10 GIR Reagent, Russel Viper Venom CRYOcheck™ LA Sure™
46 00843876000237 FDP05-10 GJT Plasma, Coagulation Factor Deficient CRYOcheck™ Factor V Deficient Plasma
47 00843876000138 CCLF-10 GGN Plasma, Coagulation Control CRYOcheck™ Low Fibrinogen Control
48 00843876000510 Hex LA Hex LA CRYOcheck Hex LA is for clinical laboratory use as a qualitative test kit intend CRYOcheck Hex LA is for clinical laboratory use as a qualitative test kit intended to aid in the detection of lupus anticoagulants (LA) in 3.2% citrated human plasma by the application of hexagonal phase phospholipids. CRYOcheck Hex LA should be used as an integrated test for lupus anticoagulant detection. For in vitro diagnostic use. The performance of this device has not been established in neonate and pediatric patient populations. GFO Activated Partial Thromboplastin 2 CRYOcheck Hex LA
49 00843876000183 APCR-05 GGN Plasma, Coagulation Control CRYOcheck™ APCR Positive Control
50 00843876000343 FDP11-10 GJT Plasma, Coagulation Factor Deficient CRYOcheck™ Factor XI Deficient Plasma
Other products with the same Product Codes "GGN, GGP"
No Primary DI Version or Model Catalog Number Device Description Brand Name Organization Name
1 00763000014919 550-11 CALCIUM CHLORIDE 5 ML NA MEDTRONIC, INC.
2 00708872000011 4036028 4036028 The Heparin/Platelet Factor 4 Antibody Serum Panel is an assayed control, intend The Heparin/Platelet Factor 4 Antibody Serum Panel is an assayed control, intended for use as a serum QC control to monitor and evaluate precision and accuracy of the (qualitative) PIFA® Heparin/PF4 Rapid Assay. Included are both confirmed positive and negative control panel members. Heparin/PF4 Antibody Serum Panel AKERS BIOSCIENCES, INC.
3 00708872000004 4036027 4036027 The Heparin/Platelet Factor 4 Antibody Serum Panel is an assayed control, intend The Heparin/Platelet Factor 4 Antibody Serum Panel is an assayed control, intended for use as a serum QC control to monitor and evaluate precision and accuracy of the (qualitative) PIFA® Heparin/PF4 Rapid Assay. Included are both confirmed positive and negative control panel members. Heparin/PF4 Antibody Serum Panel AKERS BIOSCIENCES, INC.
4 00630414170794 10873633 10873633 The Xprecia™ System PT Controls; For use with Xprecia System, supplying assayed The Xprecia™ System PT Controls; For use with Xprecia System, supplying assayed controls for prothrombin time (PT). Xprecia™ System PT Controls SIEMENS HEALTHCARE DIAGNOSTICS INC.
5 00630414025148 11065584 11065584 The Xprecia Stride™ Coagulation System is intended for use by professional healt The Xprecia Stride™ Coagulation System is intended for use by professional healthcare providers to provide an INR (InternationalNormalized Ratio) based on a Prothrobin time (PT) response for the monitoring of oral anticoagulation therapy with Warfarin. Xprecia Stride™ Coagulation Analyzer SIEMENS HEALTHCARE DIAGNOSTICS INC.
6 00627944000080 1 mL QuikCoag Control Level 3 High Abnormal BIOMEDICA DIAGNOSTICS INC
7 00627944000073 1 mL QuikCoag Control Level 2 Low Abnormal BIOMEDICA DIAGNOSTICS INC
8 00627944000066 1 mL QuikCoag Control Level 1 Normal BIOMEDICA DIAGNOSTICS INC
9 00365702129108 4625382160 4625382160 CoaguChek XS Pro PT controls ROCHE DIAGNOSTICS GMBH
10 00195226000511 0022660030 00022660030 1. Level 1 D-D Control(Cat. No. 0022660031): 5 vials x 1 mL2. Level 2 D-D Contro 1. Level 1 D-D Control(Cat. No. 0022660031): 5 vials x 1 mL2. Level 2 D-D Control(Cat. No. 0022660032): 5 vials x 1 mL HemosIL D-Dimer Controls INSTRUMENTATION LABORATORY COMPANY
11 00195226000030 0020015300 00020015300 HemosIL Apixaban Controls kit consists of:1. Apixaban Low Control (Cat. No. 0020 HemosIL Apixaban Controls kit consists of:1. Apixaban Low Control (Cat. No. 0020015310): 5 x 1 mL vials 2. Apixaban High Control (Cat. No. 0020015320): 5 x 1 mL vials HemosIL Apixaban Controls INSTRUMENTATION LABORATORY COMPANY
12 00054749001248 06P17-16 06P17-16 i-STAT ACT, CONTROL LEVEL 2 i-STAT ABBOTT POINT OF CARE INC.
13 00054749001231 06P17-15 06P17-15 i-STAT ACT, CONTROL LEVEL 1 i-STAT ABBOTT POINT OF CARE INC.
14 00054749001224 06P17-14 06P17-14 i-STAT PT, CONTROL LEVEL 2 i-STAT ABBOTT POINT OF CARE INC.
15 00054749001217 06P17-13 06P17-13 i-STAT PT, CONTROL LEVEL 1 i-STAT ABBOTT POINT OF CARE INC.
16 20812747018514 07-665US Reagent QC Level 2 Haemonetics TEG 6s HAEMONETICS CORPORATION
17 20812747018491 07-664-US Reagent QC Level 1 US Haemonetics TEG 6s HAEMONETICS CORPORATION
18 20763000014807 306-09POR CONTROL 306-09POR PORC PUR/BLK 6L 10BX N/A MEDTRONIC, INC.
19 20613994923336 306-09POR CONTROL 306-09POR PORC PUR/BLK 6L 10BX NA MEDTRONIC, INC.
20 13607450011392 01139 Pool Norm DIAGNOSTICA STAGO
21 13607450007258 00725 STA® - Deficient VIII DIAGNOSTICA STAGO
22 10888234500346 403596 403596 For Use with Factor VIII Antibody Screen Positive Control IMMUCOR GTI DIAGNOSTICS, INC.
23 10888234500339 403593 403593 For Use with Factor VIII Antibody Screen Negative Control IMMUCOR GTI DIAGNOSTICS, INC.
24 10888234500322 403591 403591 For Use with Factor VIII Antibody Screen Kit Control IMMUCOR GTI DIAGNOSTICS, INC.
25 10888234500001 F8S F8S The Factor VIII Antibody Screen is a qualitative solid phase enzyme linked immun The Factor VIII Antibody Screen is a qualitative solid phase enzyme linked immunosorbent assay (ELISA) designed to detect reactive with recombinant human factor VIII (FVIII) in human serum and plasma. Factor VIII Antibody Screen IMMUCOR GTI DIAGNOSTICS, INC.
26 10859394006184 35-201 35-201 Assayed Reference Plasma L-2 10 x 1 ml PlasmaRef ARL-2 R 2 DIAGNOSTICS, INC.
27 10859394006177 33-201 33-201 Assayed Reference Plasma 10 x 1 ml PlasmaRef ARN R 2 DIAGNOSTICS, INC.
28 10711234540046 DCJ-005 DCJ-005 Protective Sleeves directCHECK Whole Blood Controls ACCRIVA DIAGNOSTICS HOLDINGS, INC.
29 10711234170373 000DCGLR-2 000DCGLR-2 directCHECK GH100 ACTLR2 15/box directCHECK ACT-LR Whole Blood Control, Level 2 ACCRIVA DIAGNOSTICS HOLDINGS, INC.
30 10711234170366 000DCGLR-1 000DCGLR-1 directCHECK GH100 ACTLRL1 15/box. directCHECK ACT-LR Whole Blood Controls, Level 1 ACCRIVA DIAGNOSTICS HOLDINGS, INC.
31 10711234170359 000DCGACT-2 000DCGACT-2 directCHECK GH100 ACT+L2 15/box directCHECK ACT+ Whole Blood Control, Level 2 ACCRIVA DIAGNOSTICS HOLDINGS, INC.
32 10711234170342 000DCGACT-1 000DCGACT-1 directCHECK GH100 ACT+L1 15/box directCHECK ACT+ Whole Blood Control Level 1 ACCRIVA DIAGNOSTICS HOLDINGS, INC.
33 10711234170243 DCJLR-N DCJLR-N directCHECK ACT-LR - Normal 15/box directCHECK Whole Blood Controls ACCRIVA DIAGNOSTICS HOLDINGS, INC.
34 10711234170236 DCJPT-N DCJPT-N directCHECK PT - Normal 15/box directCHECK Whole Blood Controls ACCRIVA DIAGNOSTICS HOLDINGS, INC.
35 10711234170229 DCJACT-N DCJACT-N directCHECK ACT+ Normal 15/box directCHECK Whole Blood Controls ACCRIVA DIAGNOSTICS HOLDINGS, INC.
36 10711234170175 DCJCAPTT-A DCJCAPTT-A directCHECK Citrate APTT - Abnormal 15/box directCHECK Whole Blood Controls ACCRIVA DIAGNOSTICS HOLDINGS, INC.
37 10711234107102 DCP214-A DCP214-A HepCheck P214 - Abnormal 15/box HepCheck Whole Blood Control ACCRIVA DIAGNOSTICS HOLDINGS, INC.
38 10711234107096 DCP214-N DCP214-N HepCheck P214 - Normal 15/box HepCheck Whole Blood Control ACCRIVA DIAGNOSTICS HOLDINGS, INC.
39 10711234107089 DCJLR-A DCJLR-A directCHECK ACT-LR Abnormal 15/box directCHECK Whole Blood Controls ACCRIVA DIAGNOSTICS HOLDINGS, INC.
40 10711234107072 DCJCPT-N DCJCPT-N directCHECK Citrate PT - Normal 15/box directCHECK Whole Blood Controls ACCRIVA DIAGNOSTICS HOLDINGS, INC.
41 10711234107065 DCJCPT-A DCJCPT-A directCHECK Citrate PT - Abnormal 15/box directCHECK Whole Blood Controls ACCRIVA DIAGNOSTICS HOLDINGS, INC.
42 10711234107058 DCJACT-A DCJACT-A directCHECK ACT+ Abnormal 15/box directCHECK Whole Blood Controls ACCRIVA DIAGNOSTICS HOLDINGS, INC.
43 10711234107041 DCJPT-A DCJPT-A directCHECK PT - Abnormal 15/box directCHECK Whole Blood Controls ACCRIVA DIAGNOSTICS HOLDINGS, INC.
44 10711234107034 DCJAPTT-A DCJAPTT-A directCHECK APTT - Abnormal 15/box directCHECK Whole Blood Controls ACCRIVA DIAGNOSTICS HOLDINGS, INC.
45 10711234107027 DCJAPTT-N DCJAPTT-N directCHECK APTT- Normal 15/box directCHECK Whole Blood Controls ACCRIVA DIAGNOSTICS HOLDINGS, INC.
46 10711234102206 QCACT QCACT ACT Whole Blood Quality Control 40/box Hemochron Whole Blood Coagulation System ACCRIVA DIAGNOSTICS HOLDINGS, INC.
47 10629009131101 LYNCP01 A pool of normal citrated human plasma collected from a minimum of 20 donors, bu A pool of normal citrated human plasma collected from a minimum of 20 donors, buffered with 0.05M HEPES and stabilizers, dispensed and lyophilized. This plasma is used for the quality control of coagulation assays in the normal range, including fibrinogen, coagulation factors II, V, VII, VIII, IX, X XI and XII, ATIII activity, Protein C activity and Protein S activity. VisuCon-L(TM) Normal Control Plasma AFFINITY BIOLOGICALS INC
48 10629009121102 LYABP01 A pool of citrated normal human plasma collected from a minimum of 20 donors, an A pool of citrated normal human plasma collected from a minimum of 20 donors, and diluted to defined concentrations. Plasma is buffered with 0.05M HEPES and stabilizers, dispensed and lyophilized. This plasma is used for the quality control of coagulation assays in the normal range, including fibrinogen, coagulation factors II, V, VII, VIII, IX, X XI and XII, ATIII activity, Protein C activity and Protein S activity. VisuCon-L(TM) Abnormal Control Plasma AFFINITY BIOLOGICALS INC
49 10629009111103 LCSAB201 A pool of citrated human plasma collected from a minimum of 20 donors that has b A pool of citrated human plasma collected from a minimum of 20 donors that has been depleted of specific clotting factors. The plasma is buffered with 0.05M HEPES buffer and stabilizers, dispensed and lyophilized. This plasma is used for the quality control of coagulation assays (PT and APTT) in the highly abnormal range. VisuCon-L Coag Screen ABN2 Plasma AFFINITY BIOLOGICALS INC
50 10629009101104 LCSAB101 A pool of citrated human plasma collected from a minimum of 20 donors that has b A pool of citrated human plasma collected from a minimum of 20 donors that has been depleted of specific clotting factors. The plasma is buffered with 0.05M HEPES buffer and stabilizers, dispensed, and lyophilized. This plasma is used for the quality control of coagulation assays (PT and APTT) in the mid-level abnormal range. VisuCon-L Coag Screen ABN1 Plasma AFFINITY BIOLOGICALS INC